Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer

被引:83
作者
Guo, Charles C. [1 ]
Majewski, Tadeusz [1 ]
Zhang, Li [2 ]
Yao, Hui [3 ]
Bondaruk, Jolanta [1 ]
Wang, Yan [1 ]
Zhang, Shizhen [4 ]
Wang, Ziqiao [1 ]
Lee, June Goo [1 ]
Lee, Sangkyou [1 ]
Cogdell, David [1 ]
Zhang, Miao [1 ]
Wei, Peng [4 ]
Grossman, H. Barton [5 ]
Kamat, Ashish [5 ]
Duplisea, Jonathan James [5 ]
Ferguson, James Edward, III [5 ]
Huang, He [1 ]
Dadhania, Vipulkumar [1 ]
Gao, Jianjun [6 ]
Dinney, Colin [5 ]
Weinstein, John N. [3 ]
Baggerly, Keith [3 ]
McConkey, David [7 ]
Czerniak, Bogdan [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[7] Johns Hopkins Univ, Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA
来源
CELL REPORTS | 2019年 / 27卷 / 06期
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; UROTHELIAL CARCINOMA; MUTATIONAL PROCESSES; LUMINAL SUBTYPES; EXPRESSION; BREAST; PREDICTS; CHEMOTHERAPY; SIGNATURES; ALIGNMENT;
D O I
10.1016/j.celrep.2019.04.048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Sarcomatoid urothelial bladder cancer (SARC) displays a high propensity for distant metastasis and is associated with short survival. We report a comprehensive genomic analysis of 28 cases of SARC and 84 cases of conventional urothelial carcinoma (UC), with the TCGA cohort of 408 muscleinvasive bladder cancers serving as the reference. SARCs show a distinct mutational landscape, with enrichment of TP53, RB1, and PIK3CA mutations. They are related to the basal molecular subtype of conventional UCs and could be divided into epithelial-basal and more clinically aggressive mesenchymal subsets on the basis of TP63 and its target gene expression levels. Other analyses reveal that SARCs are driven by downregulation of homotypic adherence genes and dysregulation of the EMT network, and nearly half exhibit a heavily infiltrated immune phenotype. Our observations have important implications for prognostication and the development of more effective therapies for this highly lethal variant of bladder cancer.
引用
收藏
页码:1781 / +
页数:17
相关论文
共 72 条
  • [41] Fast and accurate short read alignment with Burrows-Wheeler transform
    Li, Heng
    Durbin, Richard
    [J]. BIOINFORMATICS, 2009, 25 (14) : 1754 - 1760
  • [42] Carcinosarcoma and sarcomatoid carcinoma of the bladder: Clinicopathological study of 41 cases
    Lopez-Beltran, A
    Pacelli, A
    Rothenberg, HJ
    Wollan, PC
    Zincke, H
    Blute, ML
    Bostwick, DG
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05) : 1497 - 1503
  • [43] TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
    Mariathasan, Sanjeev
    Turley, Shannon J.
    Nickles, Dorothee
    Castiglioni, Alessandra
    Yuen, Kobe
    Wang, Yulei
    Kadel, Edward E., III
    Koeppen, Hartmut
    Astarita, Jillian L.
    Cubas, Rafael
    Jhunjhunwala, Suchit
    Banchereau, Romain
    Yang, Yagai
    Guan, Yinghui
    Chalouni, Cecile
    Ziai, James
    Senbabaoglu, Yasin
    Santoro, Stephen
    Sheinson, Daniel
    Hung, Jeffrey
    Giltnane, Jennifer M.
    Pierce, Andrew A.
    Mesh, Kathryn
    Lianoglou, Steve
    Riegler, Johannes
    Carano, Richard A. D.
    Eriksson, Pontus
    Hoglund, Mattias
    Somarriba, Loan
    Halligan, Daniel L.
    van der Heijden, Michiel S.
    Loriot, Yohann
    Rosenberg, Jonathan E.
    Fong, Lawrence
    Mellman, Ira
    Chen, Daniel S.
    Green, Marjorie
    Derleth, Christina
    Fine, Gregg D.
    Hegde, Priti S.
    Bourgon, Richard
    Powles, Thomas
    [J]. NATURE, 2018, 554 (7693) : 544 - +
  • [44] Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
    McConkey, David J.
    Choi, Woonyoung
    Marquis, Lauren
    Martin, Frances
    Williams, Michael B.
    Shah, Jay
    Svatek, Robert
    Das, Aditi
    Adam, Liana
    Kamat, Ashish
    Siefker-Radtke, Arlene
    Dinney, Colin
    [J]. CANCER AND METASTASIS REVIEWS, 2009, 28 (3-4) : 335 - 344
  • [45] The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
    McKenna, Aaron
    Hanna, Matthew
    Banks, Eric
    Sivachenko, Andrey
    Cibulskis, Kristian
    Kernytsky, Andrew
    Garimella, Kiran
    Altshuler, David
    Gabriel, Stacey
    Daly, Mark
    DePristo, Mark A.
    [J]. GENOME RESEARCH, 2010, 20 (09) : 1297 - 1303
  • [46] Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]
  • [47] Mutational Processes Molding the Genomes of 21 Breast Cancers
    Nik-Zainal, Serena
    Alexandrov, Ludmil B.
    Wedge, David C.
    Van Loo, Peter
    Greenman, Christopher D.
    Raine, Keiran
    Jones, David
    Hinton, Jonathan
    Marshall, John
    Stebbings, Lucy A.
    Menzies, Andrew
    Martin, Sancha
    Leung, Kenric
    Chen, Lina
    Leroy, Catherine
    Ramakrishna, Manasa
    Rance, Richard
    Lau, King Wai
    Mudie, Laura J.
    Varela, Ignacio
    McBride, David J.
    Bignell, Graham R.
    Cooke, Susanna L.
    Shlien, Adam
    Gamble, John
    Whitmore, Ian
    Maddison, Mark
    Tarpey, Patrick S.
    Davies, Helen R.
    Papaemmanuil, Elli
    Stephens, Philip J.
    McLaren, Stuart
    Butler, Adam P.
    Teague, Jon W.
    Jonsson, Goran
    Garber, Judy E.
    Silver, Daniel
    Miron, Penelope
    Fatima, Aquila
    Boyault, Sandrine
    Langerod, Anita
    Tutt, Andrew
    Martens, John W. M.
    Aparicio, Samuel A. J. R.
    Borg, Ake
    Salomon, Anne Vincent
    Thomas, Gilles
    Borresen-Dale, Anne-Lise
    Richardson, Andrea L.
    Neuberger, Michael S.
    [J]. CELL, 2012, 149 (05) : 979 - 993
  • [48] Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
    Peinado, Hector
    Olmeda, David
    Cano, Amparo
    [J]. NATURE REVIEWS CANCER, 2007, 7 (06) : 415 - 428
  • [49] The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers
    Qian, Jun
    Hassanein, Mohamed
    Hoeksema, Megan D.
    Harris, Bradford K.
    Zou, Yong
    Chen, Heidi
    Lu, Pengcheng
    Eisenberg, Rosana
    Wang, Jing
    Espinosa, Allan
    Ji, Xiangming
    Harris, Fredrick T.
    Rahman, S. M. Jamshedur
    Massion, Pierre P.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (11) : 3469 - 3474
  • [50] Oncotator: Cancer Variant Annotation Tool
    Ramos, Alex H.
    Lichtenstein, Lee
    Gupta, Manaswi
    Lawrence, Michael S.
    Pugh, Trevor J.
    Saksena, Gordon
    Meyerson, Matthew
    Getz, Gad
    [J]. HUMAN MUTATION, 2015, 36 (04) : E2423 - E2429